Bio-Rad Laboratories

BIO • NYSE •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $610,820 $681,184 $632,124 $681,110
Gross Profit 326,466 365,900 335,683 362,483
EBITDA 99,808 150,791 148,719 141,951
EBIT 52,008 97,791 111,395 106,105
Net Income 383,916 349,708 106,257 -1,162,251
Net Change In Cash 610,820 681,184 632,124 681,110
Cost of Revenue -76,688
Free Cash Flow 28,999 38,802 53,640 63,427
Cash 433,331 403,966 457,850 390,001
Basic Shares 28,537 28,815 29,223 29,355

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $2,671,262 $2,802,249 $2,922,545 $2,545,626
Gross Profit 1,431,346 1,567,330 1,640,661 1,437,822
EBITDA 576,196 664,486 650,006 573,572
EBIT 383,796 482,616 489,430 410,957
Net Income -637,324 -3,627,535 4,254,257 3,814,229
Net Change In Cash 2,671,262 2,802,249 2,922,545 2,545,626
Cost of Revenue -39,570 -195,982 4,464
Free Cash Flow 218,263 80,290 535,718 476,408
Cash 403,966 434,215 470,783 662,205
Basic Shares 29,209 29,785 30,208 30,160

Earnings Calls

Quarter EPS
2024-03-31 $2.29
2023-12-31 $3.10
2023-09-30 $2.33
2023-06-30 $3